RESEARCH LETTER
 
TOPICS
REFERENCES (32)
1.
Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119.
 
2.
Lawrence JM, Divers J, Isom S, et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017. JAMA 2021; 326: 717-27.
 
3.
Feng K, Yuan J, Wei Y, Li M. Association between type 1 diabetes mellitus and esophageal varices: a Mendelian randomization study. Arch Med Sci 2024; 21: 605-16.
 
4.
Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes Metab Res Rev 2017; 33(2). doi:10.1002/dmrr.2841.
 
5.
Jia W, Yu R, Wang L, et al. Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study. Lancet Reg Health West Pac 2025; 55: 101463.
 
6.
Gewin LS. Sugar or fat? Renal tubular metabolism reviewed in health and disease. Nutrients 2021; 13: 1580.
 
7.
Certo M, Tsai CH, Pucino V, Ho PC, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol 2021; 21: 151-61.
 
8.
Xin Q, Wang H, Li Q, et al. Lactylation: a passing fad or the future of posttranslational modification. Inflammation 2022; 45: 1419-29.
 
9.
Cassier PA, Polivka V, Judson I, et al. Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a european phase I database. Ann Oncol 2014; 25: 1222-8.
 
10.
Wang Z, Nielsen PM, Laustsen C, Bertelsen LB. Metabolic consequences of lactate dehydrogenase inhibition by oxamate in hyperglycemic proximal tubular cells. Exp Cell Res 2019; 378: 51-6.
 
11.
Roointan A, Gheisari Y, Hudkins KL, Gholaminejad A. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: meta-analysis of profiling metabolomics studies. Nutr Metab Cardiovasc Dis 2021; 31: 2253-72.
 
12.
Jiang C, Ma X, Chen J, et al. Development of serum lactate level-based nomograms for predicting diabetic kidney disease in type 2 diabetes mellitus patients. DMSO 2024; 17: 1051-68.
 
13.
Tang L, Yang Q, Ma R, et al. Association between lactate dehydrogenase and the risk of diabetic kidney disease in patients with type 2 diabetes. Front Endocrinol 2024; 15: 1369968.
 
14.
ElSayed NA, Aleppo G, Aroda VR, et al. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 2023; 46 (Suppl 1): S19-40.
 
15.
Weng J, Zhou Z, Guo L, et al. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ 2018; 360: j5295.
 
16.
American Diabetes Association Professional Practice Committee. Chronic kidney disease and risk management: standards of medical care in diabetes-2022. Diabetes Care 2022; 45 (Suppl 1): S175-84.
 
17.
Saffari SE, Volovici V, Ong MEH, et al. Proper use of multiple imputation and dealing with missing covariate data. World Neurosurg 2022; 161: 284-90.
 
18.
Zager RA, Johnson ACM, Becker K. Renal cortical lactate dehydrogenase: a useful, accurate, quantitative marker of in vivo tubular injury and acute renal failure. PLoS One 2013; 8: e66776.
 
19.
Zhu L, Zheng Q, Liu X, et al. HMGB1 lactylation drives neutrophil extracellular trap formation in lactate-induced acute kidney injury. Front Immunol 2024; 15: 1475543.
 
20.
Liu JJ, Liu S, Gurung RL, et al. Urine tricarboxylic acid cycle metabolites predict progressive chronic kidney disease in type 2 diabetes. J Clin Endocrinol Metab 2018; 103: 4357-64.
 
21.
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia 1989; 32: 219-26.
 
22.
Han Q, Zou Y, Yang Q, Ran E, Li Z, Liu F. CD4+ T-cell-derived small extracellular vesicles induce the apoptosis of renal tubular epithelial cells in diabetic nephropathy by regulating mitochondrial dynamics. Biochim Biophys Acta Mol Basis Dis 2026; 1872: 168131.
 
23.
Zhao K, Zhao W, Hu X, et al. Carnosine alleviates high glucose-induced renal tubular cell pyroptosis by activating the AMPK/SIRT3/SOD2 pathway. Free Radic Res 2026; 60: 169-82.
 
24.
Zhang Y, Wen P, Luo J, et al. Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death Dis 2021; 12: 847.
 
25.
Shen X, Liu Y, Zhao J, Cheng Q, Yang G. Effects of inflammation on hypoxic renal tubular epithelial cell injury under high-glucose conditions and the regulatory role of miR-125b. Sci Rep 2025; 15: 21248.
 
26.
Xiao X, Zhang J, Lang Y, et al. Associations of lactate dehydrogenase with risk of renal outcomes and cardiovascular mortality in individuals with diabetic kidney disease. Diabetes Res Clin Pract 2023; 203: 110838.
 
27.
Ryu SY, Kleine CE, Hsiung JT, et al. Association of lactate dehydrogenase with mortality in incident hemodialysis patients. Nephrol Dial Transplant 2021; 36: 704-12.
 
28.
Merkuri F, Rothstein M, Simoes-Costa M. Histone lactylation couples cellular metabolism with developmental gene regulatory networks. Nat Commun 2024; 15: 90.
 
29.
Li J, Hou W, Zhao Q, et al. Lactate regulates major zygotic genome activation by H3K18 lactylation in mammals. Natl Sci Rev 2024; 11: nwad295.
 
30.
Li X, Hu L, Hu Q, Jin H. Lactate and lactylation in the kidneys: current advances and prospects (review). Int J Mol Med 2025; 56: 1-14.
 
31.
Zhang X, Chen J, Lin R, et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway. Redox Biol 2024; 75: 103246.
 
32.
Zheng T, Gu YP, Wang JM, Huang TT, Gou LS, Liu YW. Lactate-triggered histone lactylation contributes to podocyte epithelial-mesenchymal transition in diabetic nephropathy in mice. Chemicobiol Interact 2025; 408: 111418.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top